4.7 Article

A novel Affibody bioconjugate for dual-modality imaging of ovarian cancer

期刊

CHEMICAL COMMUNICATIONS
卷 50, 期 85, 页码 12832-12835

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c4cc03454f

关键词

-

资金

  1. Office of Science (BER), U.S. Department of Energy [DE-SC0008397]
  2. National Cancer Institute (NCI) [R01 CA128908-03]
  3. NCI In Vivo Cellular Molecular Imaging Center (ICMIC) [P50 CA114747]
  4. China National Key Research and Development Program 973 Project [9732006CB933205]
  5. Science and Technology Pillar Program of Jiangsu province [BE2010721]

向作者/读者索取更多资源

An Affibody based dual imaging probe (PET and optical imaging) has been successfully developed. Dendrimer PAMAM G0 was used as a platform to assemble an NIRF dye, a metal chelator, and Affibody for dual modality imaging of ovarian cancer. Excellent tumor imaging quality was achieved in both modalities in the living tumor mice models.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据